Vol. 7, Issue 6 (2018)
Cord cells transplantation: The source of regenerative medicine
Neeti Chana and Harvinder Popli
The success of umbilical cord stem cell transplantation has seen many changes over the last 30 years. Over time medical line has witnessed successful allogeneic and autologous transplants for the malignant and non-malignant hematological and immunological diseases. These were pioneered by the cord stem cells, which became the future therapy and are known to us as “Regenerative medicines”. There has been the establishment of private and public banks for cord blood and tissue preservation all across the globe. Successful preservation of cord cells had helped to develop minimally manipulated products for allogeneic hematopoietic reconstitution. About 345 clinical trials using mesenchymal stem cells from cord tissue are under process for discovering treatment methodologies for unlocking new possibilities. This paper captures information about cord blood banking, transplantation and current status of clinical research, to create awareness and knowledge among the readers about the subject
How to cite this article:
Neeti Chana, Harvinder Popli. Cord cells transplantation: The source of regenerative medicine. Pharma Innovation 2018;7(6):210-215.